Grifols Biemat (GRFS) - Uzoq muddatli qarzning kapitalga koeffitsiyenti

Grifols Biemat - GRFS emitenti grafik logotipi

Grifols, S.A. (GRFS) aksiyalarining narx dinamikasi 1.36 joriy darajasini aks ettirmoqda. Grifols, S.A. (GRFS) o'zining global ta'minot zanjiri bo'ylab xomashyolarni tashish jarayonida qat'iy harorat nazoratini ta'minlaydi. Biznes daromadlari donor plazmasidan olingan albumin va immunoglobulinlar savdosi orqali shakllantiriladi. Uning global yetakchi maqomi va texnik jarayonlarning murakkabligi emitentga o'zining muhim dori vositalari bo'yicha narxlarni belgilash imkoniyatini saqlab qolishga imkon beradi.

Grifols SA (GRFS): Uzoq muddatli qarzning o'z kapitaliga nisbati 04.07.2022dan 30.10.2026gacha

Grifols, S.A. (GRFS) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- aksiya narxi va konsensus maqsadli narx:
Kotirovkalar grafigi Grifols SA|GRFS - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi ko'rsatkichlari:
Bozor qiymati Grifols, S.A.|GRFS - Korxona qiymati
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
Bitta aksiya hisobiga balans qiymati Grifols|GRFS - Kompaniyaning balans qiymati|Balans qiymatiga nisbatan bozor qiymati grifols.com|GRFS - Kompaniyaning jami aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Grifols, S.A.|GRFS - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati grifols.com|GRFS - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati Grifols, S.A.|GRFS - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz hajmi Grifols|Tezkor likvidlik ko‘rsatkichi grifols.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
GRFS - Kompaniyaning sof foydasi
Kompaniyaning umumiy tahlili:Grifols SA - GRFS
Grifols, S.A. brend mahsuloti

Logistika va IT infratuzilmasini autsorsing qilish Grifols, S.A. (GRFS) kompaniyasiga kapital xarajatlarini optimallashtirish imkonini beradi, bu esa uzoq muddatli qarzning kapitalga nisbati ko'rsatkichiga bevosita ta'sir qiladi. Ushbu ko'rsatkich bir yildan ortiq muddatga ega majburiyatlarning kapitalga nisbatdagi ulushini o'lchaydi hamda qattiq pul-kredit siyosati davrida biznesning leveraj darajasini va uning umumiy moliyaviy barqarorligini belgilaydi.

Muhim raqobatchilar

argenx N.V. - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati BNTX|ABVX (Abivax S.A.) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati ADMA (ADMA Biologics)|Uzoq muddatli qarzning kapitalga nisbati protagonist-inc.com PTGX|IMVT - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti KNSA (Kiniksa Pharmaceuticals, Ltd.)|Adaptive Biotechnologies Corp (ADPT) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Celldex Corp|AUPH (Aurinia Pharmaceuticals) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati biocryst.com|Uzoq muddatli qarzning o'z kapitaliga nisbati VERA (Vera Therapeutics)|DNTH (Dianthus Therapeutics Inc) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati PHVS (Pharvaris Corp)|Uzoq muddatli qarzdorlikning kapitalga nisbati AbCellera (ABCL)|TRML - Uzoq muddatli qarzning o'z kapitaliga nisbati|precigen.com (PGEN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Pharming Group (PHAR) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Nektar Therapeutics Inc|Uzoq muddatli qarzning o'z kapitaliga nisbati UPB|Uzoq muddatli qarzning kapitalga nisbati Zenas Corp|Uzoq muddatli qarzning o'z kapitaliga nisbati Immunome, Inc. (IMNM)|gossamerbio.com - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati KALV (KalVista Pharmaceuticals, Inc.)|Septerna, Inc. (SEPN) - Uzoq muddatli majburiyatlarning kapitalga nisbati|Pieris Pharmaceuticals Inc - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning o'z kapitaliga nisbati Savara Pharma (SVRA)|Rigel Pharmaceuticals (RIGL) - Uzoq muddatli qarzning o'z kapitaliga nisbati|anaptysbio.com - Uzoq muddatli qarzning kapitalga koeffitsiyenti|ATXS (Astria Therapeutics, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|enGene Holdings Inc (ENGN) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati RAPT|JBIO: Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Aclaris Therapeutics ACRS|kyvernatx.com (KYTX) - Uzoq muddatli majburiyatlarning kapitalga nisbati|TLSA - Uzoq muddatli qarzning o'z kapitaliga nisbati|CABA: Uzoq muddatli qarzning o'z kapitaliga nisbati|Ventyx Bio (VTYX) - Uzoq muddatli qarzning o'z kapitaliga nisbati|THTX - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati AVTX|ELDN: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Agenus Inc. (AGEN)|Uzoq muddatli qarzdorlikning kapitalga nisbati Climb Bio Inc.|Zura Bio Limited - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati aTyr Pharmaceuticals (ATYR)|Adagene Corp - Uzoq muddatli qarzning kapitalga nisbati|IMA - Uzoq muddatli qarzning kapitalga nisbati|STTK (shattucklabs.com) - Uzoq muddatli qarzning o'z kapitaliga nisbati|EQ - Uzoq muddatli qarzdorlikning kapitalga nisbati|CNTB (Connect Biopharma Holdings) - Uzoq muddatli qarzning kapitalga nisbati|IMUX - Uzoq muddatli qarzdorlikning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Atara Biotherapeutics (ATRA)|IFRX (inflarx.de) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati XFOR (X4 Pharmaceuticals, Inc.)|ACET (Adicet Bio Inc.) - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|CELU - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati INmune Bio Corporation INMB|Barinthus Biotherapeutics (BRNS) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati KZR (kezarlifesciences.com)|SABS (SAB Biotherapeutics, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|AKTX: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati ENLV|Uzoq muddatli qarzning kapitalga nisbati q32bio.com (QTTB)|Uzoq muddatli qarzning o'z kapitaliga nisbati GeoVax Labs, Inc. GOVX|Uzoq muddatli qarzning kapitalga koeffitsiyenti EDSA|IBIO - Uzoq muddatli qarzning o'z kapitaliga nisbati|Carisma Therapeutics (CARM) - Uzoq muddatli qarzning o'z kapitaliga nisbati|XTLB: Uzoq muddatli qarzning kapitalga nisbati|Bolt Biotherapeutics, Inc. (BOLT) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati HCWB|APVO: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati AIM|Uzoq muddatli qarzdorlikning kapitalga nisbati aditxt.com|Uzoq muddatli qarzning o'z kapitaliga nisbati GRI Bio Corp GRI|XRTX - Uzoq muddatli qarzning o'z kapitaliga nisbati|HIND - Uzoq muddatli qarzning o'z kapitaliga nisbati|revbiosciences.com (REVB) - Uzoq muddatli qarzning o'z kapitaliga nisbati|INDP (Indaptus Therapeutics, Inc.) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Scinai Immunotherapeutics Ltd (SCNI) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati CalciMedica Inc|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi AFMD (Affimed Therapeutics)|Uzoq muddatli qarzning kapitalga nisbati ALLK|HOOK - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati IGMS (IGM Biosciences)|Uzoq muddatli qarzdorlikning o'z kapitaliga nisbati iTeos Therapeutics Inc|OCEA - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti TCBP (TC BioPharm Ltd)|THRD: Uzoq muddatli qarzning kapitalga nisbati